Severe thrombocytopenia after trastuzumab in a patient with HER2-positive serous endometrial cancer.

Kucera, Celia; Chappell, Nicole; Wang, Stephanie

Kucera, Celia; Chappell, Nicole; Wang, Stephanie.

Affiliation

Kucera C; Department of Obstetrics and Gynecology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA ckucera@gwu.edu.
Chappell N; Department of Obstetrics and Gynecology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Wang S; Department of Obstetrics and Gynecology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.

BMJ Case Rep ; 16(6)2023 Jun 01.

Article in En | MEDLINE | ID: mdl-37263678

Subject(s)

Breast Neoplasms; Carcinoma; Endometrial Neoplasms; Thrombocytopenia; Uterine Neoplasms; Humans; Female; Trastuzumab/adverse effects; Antibodies, Monoclonal, Humanized/adverse effects; Receptor, ErbB-2/metabolism; Antibodies, Monoclonal/adverse effects; Endometrial Neoplasms/drug therapy; Uterine Neoplasms/pathology; Thrombocytopenia/chemically induced; Antineoplastic Combined Chemotherapy Protocols/adverse effects

Key words

Cancer - see Oncology; Cancer intervention; Gynecological cancer; Haematology (drugs and medicines); Obstetrics, gynaecology and fertility

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Uterine Neoplasms / Breast Neoplasms / Carcinoma / Endometrial Neoplasms Limits: Female / Humans Language: En Journal: BMJ Case Rep Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google